Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer

OBJECTIVE: To evaluate the relationship between pre‐operative PSA value, (68)Ga‐prostate‐specific‐membrane‐antigen (PSMA) PET performance and oncologic outcomes after salvage lymph node dissection (sLND) for biochemical recurrent prostate cancer (PCa). PATIENTS AND METHODS: The study included 164 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bravi, Carlo A., Heidenreich, Axel, Fossati, Nicola, Gandaglia, Giorgio, Suardi, Nazareno, Mazzone, Elio, Stabile, Armando, Cucchiara, Vito, Osmonov, Daniar, Juenemann, Klaus‐Peter, Karnes, R. Jeffrey, Kretschmer, Alexander, Buchner, Alexander, Stief, Christian, Hiester, Andreas, Albers, Peter, Devos, Gaëtan, Joniau, Steven, Van Poppel, Hendrik, Grubmüller, Bernhard, Shariat, Shahrokh, Tilki, Derya, Graefen, Markus, Gill, Inderbir S., Mottrie, Alexander, Karakiewicz, Pierre I., Montorsi, Francesco, Briganti, Alberto, Pfister, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766859/
https://www.ncbi.nlm.nih.gov/pubmed/36569505
http://dx.doi.org/10.1002/bco2.182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766859/
https://www.ncbi.nlm.nih.gov/pubmed/36569505
http://dx.doi.org/10.1002/bco2.182

Ejemplares similares